ALC vs FBRX
Alcon Inc vs Forte Biosciences, Inc. — AI-powered side-by-side comparison
VS
FBRX
Forte Biosciences, Inc.
59
Watch
| Metric | ALC | FBRX |
|---|
| AI Score |
68
|
59
|
| Price |
$75.39
|
$76.88
|
| P/E Ratio |
45.39×
|
-16.78×
|
| ROE |
4.4%
|
-113.7%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
54.9%
|
0.0%
|
| Debt / Equity |
0.24×
|
0.00×
|
| Dividend Yield |
0.5%
|
0.0%
|
| RSI (14) |
73.4
|
85.6
|
| Beta |
0.703
|
2.645
|
| Expected Upside |
+11.3%
|
—
|
AI Committee View
Current Innellis committee reasoning for ALC versus FBRX.
ALC leads by 9 points.
ALC scores 68/100 (Buy) versus FBRX at 59/100 (Watch).
ALC Committee View
75% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is rsi at 73 is in overbought territory. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- RSI at 73 is in overbought territory — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
FBRX Committee View
50% agreement
4 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 80.8% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- RSI at 86 is in overbought territory — Technical
- MACD histogram negative -- bearish momentum — Technical
- Weekly RSI at 92 -- overbought on the larger timeframe too — Technical